Monthly Archives: May 2020

Many clinical studies have shown promising results about the health benefits of CBD.

The studies have also shown it to have no psychoactive properties as perceived until recently.

These findings have encouraged lawmakers to relax rules around CBD products. This, in turn, has made a lot of people curious about different CBD products.

However, considering it to be a great opportunity, many sellers have started selling different types of CBD products including CBD tinctures under different brand names.

This has created a lot of confusion about these products in the minds of the consumers.

Therefore, it is important for you to be aware of the factors that you should consider before buying CBD Oil.

For this, you should consult your physician to know if CBD oil can relieve you of your ailments. Consult also about the method of consuming CBD.

Each method of consumption provides a different level of effectiveness.

For instance, taking oil sublingually would take a little more time to offer the relief; however, it would last for a longer time. On the other hand,the vaping pen would provide instant relief from pain & anxiety.

For a good quality CBD oil you need to consider the following important factors related to its ingredients.

Before that we also recommend checking out cbdfable.com for genuine CBD brand reviews and informational stuff on cannabidiol.

Marijuana and Hemp plants are the two major plant sources of CBD extract. The use of Marijuana for manufacturing CBD oil is restricted at the US federal level due to its higher THC levels.

While CBD extracted from Hemp plants are allowed at the federal level. Many states in the US have also legalized activities related to CBD products with THC levels less than 0.3%.

Therefore, before buying ensure that the CBD oil is extracted through Hemp plants and not through Marijuana.

There are many manufacturers who use different chemicals in the form of pesticides and fertilizers, etc. These chemicals are harmful for human consumption.

Reputed sellers only use organically grown hemp plants in their CBD products. So, ensure that the CBD oil that you buy uses organic hemp plants in its extraction.

The most commonly used carrier oil includes; Hemp Oil, Olive Oil, and MCT Oil.

Each carrier oil has some distinct properties that it imparts to the final product.

If Hemp Oil would add on to the potency of the CBD Oil, it would also impart its weedy note to the product.

MCT Oil which is a derivative of coconut oil imparts many different health benefits to the product besides offering a light & sweet flavor to it.

Olive oil, similarly, would add on to the properties of the CBD Oil while making it smell a bit strong and intense.

Some of the manufacturers use flavors and aromas to enhance the taste and smell profile of their products.

You should check if the minor ingredients used in the oil are also natural plant extracts and are not derived chemically.

The manufacturing process plays a vital role in determining the quality of CBD Oil. The following are the factors you must check before buying your CBD Oil.

Many manufacturers use different chemical solvents in extracting CBD from the hemp plant. These chemicals may carry forward their harmful properties in the final product.

However, most of the reputed manufacturers use CO2 extraction methods to extract CBD. This process does not involve any kind of chemicals and also provides a very effective CBD extract.

A hemp plant contains many compounds other than CBD. This includes THC, photochemical, and terpenes, etc.

While THC has psychoactive properties, many other compounds are rich sources of nutrients and enhance the quality of the CBD oil.

Different CBD extracts contain different compounds.

A full-spectrum CBD extract would contain all the compounds of the hemp plant. This makes this extract highly effective but at the same time makes it a little susceptible as the extract also contains THC.

A broad-spectrum extract would have all the compounds excluding THC in it.

CBD isolates would not contain any compound other than CBD.

Even the best quality of CBD oil can degrade due to the oxidation process or by reacting to the packaging material.

Glass is the least reactive of all the practically available packaging materials. And if the glass bottle has a dark color it prevents light to enter the bottle thus avoiding oxidation of CBD Oil.

Therefore, it is better to buy your CBD oil in a dark-colored glass bottle for longer life.

You should ensure proper content levels of CBD & THC in the CBD oil.

Check for the CBD contents in the CBD oil. Check the amount of CBD (mg) per ml of CBD oil and buy as per your requirement.

Another very important factor is the THC content. It is illegal in most of the states in the US to use CBD oil with more than 0.3% THC levels. Therefore, ensure that your CBD oil does not have more than the allowable limits of THC in it.

One of the ways to ensure the authenticity of the claims of different sellers is to check for the third party analysis report of the product.

A reputed company would transparently share its third-party lab reports on its website. Buy from these companies to be on the safer side.

This is one of the most important factors to ensure the quality of CBD oil.

A reputed brand earns its reputation through consistent delivery of quality products over time. And it cannot afford to spoil it by offering inferior products.

So, go for the reputed brand if you wish to ensure the good quality of CBD oil.

Check your budget and buy accordingly. However, do not compromise with the quality of the product.

At the same time, if you have a low budget avoid buying products with non-value adding features.

It is always a good idea to know the important factors to consider before buying any product. It helps you in making an informed decision and making the right choices.

These were some important factors to consider before buying CBD oil. We hope that this would help you in taking the right decision.

Finally, we would suggest you consult your physician and also to check the local laws prevailing in the respective state before buying your CBD oil.

Follow this link:

Things to consider when buying CBD oil - AZ Big Media

ATLANTA, GA / ACCESSWIRE / May 20, 2020 / It seems like CBD is being talked about everywhere nowadays. A recent Gallup Poll showed that 14% (45 million) of Americans reported using CBD products and the reason they were using CBD oil was for pain relief. With the passing of the 2018 Farm Bill, the US laid the foundation for the rapid expansion of the CBD market.

CBD Oil and Pain Relief: a Dose of Evidence

According to Peter Grinspoon, MD at the Harvard Health Publishing "CBD may offer an option for treating different types of chronic pain. A study from the European Journal of Pain showed, using an animal model, CBD applied on the skin could help lower pain and inflammation due to arthritis. Another study demonstrated the mechanism by which CBD inhibits inflammatory and neuropathic pain, two of the most difficult types of chronic pain to treat. More study in humans is needed in this area to substantiate the claims of CBD proponents about pain control." [Source]

Along these lines, marijuana is said to be a fantastic muscle relaxant, and people swear by its ability to lessen tremors in Parkinson's disease. Watch this extraordinary video to see CBD in action (warning: you may get emotional). A single drop of CBD eliminates a Parkinson's patient's symptoms in 3 minutes.

A leading CBD resource, bioMD+, recently published an article titled "How To Use CBD Oil for Pain" in which they highlight relevant CBD research in this area. Read it here: https://biomdplus.com/how-to-use-cbd-oil-for-pain/

Cannabidiol (CBD)

Cannabinoids are a group of compounds that mediate their effects through cannabinoid receptors. The discovery of 9-tetrahydrocannabinol (THC) as the major psychoactive principle in marijuana, as well as the identification of cannabinoid receptors and their endogenous ligands, has led to significant growth in research aimed at understanding the physiological functions of cannabinoids.

Cannabinoid receptors include CB1, which is predominantly expressed in the brain, and CB2, which is primarily found on the cells of the immune system.

CBD Oil Benefits

The most popular use of CBD is its utilization for pain relief and pain management. It is reported that 40% of users use CBD for pain relief. CBD's role in pain management has been demonstrated in research studies and embraced by celebrities and a growing number of professional athletes. In one study in 2014 published in the Hawaii Journal of Medicine and Public Health, CBD users reported a 64% decrease in average pain levels.

In a crowded market with little regulation, consumers looking for CBD products are often unable to find effective products. A leading CBD resource, PopularCBDBrands.com, recently published an article titled "CBD Oil Provides Pain Relief" in which they highlight relevant CBD research in this area and make recommendations for the top CBD oil for pain.

Based on their testing and analysis of hundreds of brands, the top company chosen in the article is bioMD+. This company is based in Marietta, Georgia, and has become a new standard for effectiveness and transparency in the CBD industry. The article explains how bioMD+ earned this reputation through its commitment to quality.

bioMD+ uses nothing but Organic Colorado-grown hemp and enhances each of their hemp oil products with a blend of natural terpenes design for maximum support for the effectiveness of the cannabinoids. Their CBD Oils are refined through a Supercritical C02 extraction process and then further purified into Winterized oil - a step which few other companies seek in efforts to cut costs. In each of their different CBD oil products contain 1,000mg of CBD per bottle, and lab results made directly available so the customer knows exactly what they are buying.

Story continues

Read the original post:

How To Use CBD Oil for Pain: What is the Best CBD Oil as an Alternative to Prescription Drugs? - Yahoo Finance

Share this idea!

Proponents insist that CBD oil is capable of curing a wide variety of ailments, from anxiety to nerve pain. But is it the miraculous cure-all wed like it to be?

CBD oil is a natural product that has gained popularity in recent years, thanks, in part, to the legalization of cannabis in many states. Youve likely seen businesses advertise that theyre now selling CBD oil (and similar products), and heard various claims about what constitutes the best CBD oil.

Lets start by explaining what CBD oil is. CBD stands for cannabidiol, which is a cannabinoid, a non-psychoactive compound found in cannabis plants. CBD oil is a concentrated form of CBD that is separated from other components of cannabis. Its available in a wide variety of products, ranging from drops, capsules, and edibles to topical creams.

Note that CBD is non-intoxicating; it does not make you high. A different cannabis compound called THC is responsible for the high feeling associated with consuming cannabis.

What is the evidence for CBD oil as a beneficial remedy?

One of the most common claims of CBD proponents is that CBD oil can relieve anxiety. Generally speaking, theres evidence to suggest that this is true. According to a study by the National Institute on Drug Abuse, CBD oil is shown to reduce stress in animals like rats. Research subjects treated with CBD showed lower signs of behavioral anxiety, as well as fewer physical symptoms of generalized anxiety, like high heart rate.

Research on humans has also been promising. For example, one scientific study found multiple studies supporting the benefits of using CBD when treating post-traumatic stress disorder (PTSD), a disorder related to anxiety.

Because CBD produces a relaxing effect, some people may find it useful in treating anxiety-induced insomnia.

One study, which examined the sleep patterns of 103 adults, found that CBD use was capable of decreasing anxiety and improving sleep in about 66.7 percent of subjects. However, this rate fluctuated over time, suggesting that the effects of CBD may not be entirely consistent. The research also showed very low risk associated with CBD use. Only three subjects did not tolerate CBD oil well.

CBD has also been claimed to be an effective treatment for depression, but the evidence is sparse.

One review from 2017 suggested that there isnt currently enough evidence to support CBD as an effective treatment for depression. This review also concluded that CBD may be effective for treating anxiety symptoms. However, it pointed out that many of the largest and best-received studies thus far have lacked rigorous scientific standards, such as the presence of a control group.

Other studies have suggested possible uses for CBD oil in other areas related to psychotherapy. For example, one study from 2016 found that CBD could have antipsychotic effects in some people suffering from schizophrenia. The substance also doesnt have the same debilitating side effects linked to most other conventional antipsychotic drugs.

There is early supporting evidence that CBD (and other cannabinoids) may reduce tumor growth at least in animal models. For example, one 2019 review of both in vitro and in vivo studies on pancreatic cancer development found that cannabinoids reduce tumor invasion, slow tumor growth, and in some cases, can even cause death of tumor cells. However, the exact mechanisms responsible for this effect are in debate, and factors like appropriate dosing are not yet clear.

CBD may also improve the uptake or potency of certain cancer treatment drugs. Its also considered an antiemetic, which can be useful in specific types of cancer treatment.

For people suffering from severe forms of epilepsy or seizures, CBD may be an effective treatment. In fact, the prescription drug Epidiolex was contains CBD. When taken orally, Epidiolex can reduce the number of seizures suffered by a patient. However, its worth noting that the patients in these studies were taking Epidiolex with at least two other epilepsy drugs and were suffering from an extreme form of epilepsy (i.e., Lennox-Gastaut syndrome or Dravet syndrome).

Epidiolex is the first FDA-approved drug made from cannabis; researchers are eager to learn more about how and why cannabidiol protects against seizures.

CBD can also function as an anti-inflammatory and an analgesic, according to some studies.

In these applications, CBD can be applied topically, usually as a spray. Anecdotally, sufferers of arthritis and similar forms of chronic pain have found relief when regularly applying CBD. As with many of the other potential applications for CBD, we need more research for a definitive analysis of its effectiveness for pain management.

Additionally, early research shows CBD to be well-tolerated by humans and animals. A review from 2011 suggests that CBD is non-toxic in non-transformed cells and does not induce changes on food intake, does not induce catalepsy, does not affect physiological parameters (heart rate, blood pressure and body temperature), does not affect gastrointestinal transit and does not alter psychomotor or psychological functions. This study covered even high doses of up to 1,500 mg of CBD per day.

There is some evidence that there may be long-term side effects of CBD, such as inhibition of hepatic drug metabolism, decreased fertilization rates, and alterations of in vitro cell viability. We need more research to confirm the extent and occurrence rate of these side effects.

Short-term side effects from CBD seem to be rare and limited, but can include diarrhea, fatigue, changes in weight, and changes in appetite. Its also unknown how and when CBD may interfere with medications and dietary supplements. Thus far, CBD appears to be less habit-forming than substances like alcohol and tobacco but may produce withdrawal symptoms if someone uses it consistently for an extended period of time then suddenly stops.

CBD oil appears to have some evidence-backed benefits for humans, with limited side effects. But its still something we dont know a lot about. The FDA does not yet regulate CBD, and warns that there are unanswered questions about its safety. Future studies may reveal important information about its applications for human health.

If you want to start taking CBD oil, consider talking to your doctor first.

Feature image byJulia TeichmannfromPixabay

Continue reading here:

Is CBD Oil the Natural Cure-All We Want It To Be? - Earth911.com

As we all continue to navigate this challenging new normal amidst the COVID-19 pandemic, consumers need accurate information about effective precautions to prevent the spread of coronavirus.

No proven treatments exist yet for COVID-19, nor is there a vaccine. That is why social distancing and good hygiene practices are so important to prevent the spread of the virus.

Across the United States, people are rising to the challenge, but a cynical minority has seized on the crisis to promote unscrupulous, and frankly dangerous, marketing claims about CBD products conferring immunity against the coronavirus and providing relief for those infected.

These false claims touting unproven medical benefits are nothing more than craven attempts to take advantage of fearful consumers. Moreover, it spreads misinformation among consumers anxiously seeking ways to stay safe and healthy amidst the coronavirus crisis.

A CBD store in Portland, Oregon was ordered by the office of the state's attorney general to remove signs claiming that its products could boost immunity against COVID-19. Last month, New Yorks attorney general ordered a companyto immediately cease and desist the marketing of their product as a means of curing the coronavirus.

There have been numerous reports of a fabricated news story promoting CBD oil as a treatment for the virus that was shared across the country through texts and social media, pointing unsuspecting consumers to a CBD sales site. Former All-Pro NFL offensive lineman, Kyle Turley, was promoting CBD products in the fight against COVID-19. Turley received warnings from the FDA and the Federal Trade Commission, and since then, these false claims have thankfully stopped.

During this time of heightened attention on wellness and prevention, consumers must be aware that CBD products have not been tested or evaluated by the U.S. Food and Drug Administration (FDA). Recent studies have also found potential harmful side effects from consuming cannabis products with Tetrahydrocannabinol (THC) if a patient is infected with COVID-19. Studies have shown that many unregulated CBD products have been found to contain THC the primary psychoactive compound in marijuana though the labels may not disclose this.

Unregulated, untested CBD products present an increasing threat to public health. Consumers risk illness, exposure to THC and contaminants including lead, arsenic, pesticides and toxic mold. The vast majority of CBD on the shelves today fail to meet even the most basic safety and efficacy standards. CBD carries potential risks, including liver toxicity, fatigue and harmful interaction with other drugs. Not one scintilla of credible scientific evidence indicates that CBD products prevent the spread of the coronavirus. Consumers need to know these facts.

A recent report from the FDA to Congress underscores many of the warnings expressed by Consumers for Safe CBD and the Consumer Federation of America. While the FDA report is a step in the right direction, coupled with the agencys warning letters to companies illegally selling various products containing cannabidiol and updates on a variety of safety concerns, much more work remains to protect consumers.

Consumers deserve the gold standard protection that the FDA has provided for decades. We want and need access to sound, reliable information about CBD. Today more than ever, the FDA must stop bad actors from making false medical claims and encourage the further testing of CBD.

In these uncertain times, we urge consumers to take precautions and follow CDC guidelines, practice social distancing and avoid untested, unregulated products. As we collectively adjust to the realities of this global pandemic, we must increase efforts to protect consumer health and safety.

Sally Greenberg is the executive director of the National Consumers League. Thomas Gremillion is the director of Food Policy for the Consumer Federation of America.

See original here:

Buyer beware: False medical claims about CBD and COVID-19 | TheHill - The Hill

Summitt Labs is voluntarily recalling Kore Organic Watermelon CBD Oil Tincture because it contains a high level of lead.

According to an announcement with the U.S. Food and Drug Administration, the Florida Department of Agriculture and Consumer Services tested a random sample and found a lead level of 4.7 ppm.

Summit Labs had the same batch tested by another lab, which found .5 ppm, which is within the legal limit.

However, Summit opted to recall the batch No. 730, Lot No. K018.

According to the USFDA, the product has a Kore Organic Logo and kraft paper packaging. There are nine, 30 milliliter bottles per package.

The product was distributed nationwide by I.E. Nirvana Kulture and North East Rally.

According to the Florida Department of Health, acute lead poisoning could have signs and symptoms including but not limited to pain, muscle weakness, paresthesia, abdominal pain, nausea, vomiting, diarrhea, constipation, poor appetite, weight loss, symptoms associated with encephalitis, metallic taste in the mouth, shock, hemolysis and kidney damage.

For more information, contact Summit Labs at 833-810-5673, 8 a.m.-5 p.m. weekdays.

READ MORE

Thanks for visiting PennLive. Quality local journalism has never been more important. We need your support. Not a subscriber yet? Please consider supporting our work.

Follow this link:

Kore Organic Watermelon CBD Oil Tincture recalled because of high levels of lead - PennLive

Global Organic CBD Hemp Oil Market Growth Projection

The new report on the global Organic CBD Hemp Oil market is an extensive study on the overall prospects of the Organic CBD Hemp Oil market over the assessment period. Further, the report provides a thorough understanding of the key dynamics of the Organic CBD Hemp Oil market including the current trends, opportunities, drivers, and restraints. The report introspects the micro and macro-economic factors that are expected to nurture the growth of the Organic CBD Hemp Oil market in the upcoming years and the impact of the COVID-19 pandemic on the Organic CBD Hemp Oil . In addition, the report offers valuable insights pertaining to the supply chain challenges market players are likely to face in the upcoming months and solutions to tackle the same.

The report suggests that the global Organic CBD Hemp Oil market is projected to reach a value of ~US$XX by the end of 2029 and grow at a CAGR of ~XX% through the forecast period (2019-2029). The key indicators such as the year-on-year (Y-o-Y) growth and CAGR growth of the Organic CBD Hemp Oil market are discussed in detail in the presented report. This data is likely to provide readers an understanding of qualitative and quantitative growth prospects of the Organic CBD Hemp Oil market over the considered assessment period.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2576439&source=atm

The report clarifies the following doubts related to the Organic CBD Hemp Oil market:

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2576439&source=atm

Segmentation of the Organic CBD Hemp Oil Market

The following manufacturers are covered:KazmiraCW Hemp/CW BotanicalsFreedom LeafGreen RoadsMedical MarijuanaFolium BiosciencesHempLife TodayCannavestPharmahempENDOCACBD American ShamanNuLeaf Naturals

Segment by RegionsNorth AmericaEuropeChinaJapan

Segment by TypeHigh Quality StandardLow Quality Standard

Segment by ApplicationPharmaceutical IndustryFood IndustryCosmetics Industry

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2576439&licType=S&source=atm

Vital Information Enclosed in the Report

Read the rest here:

Organic CBD Hemp Oil Product Witness (es) Dampening Sales as ABC End-use Industry Suffers Massive Blow Due to COVID-19 Pandemic - Cole of Duty

SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the Company, CV Sciences, our, us or we), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that on May 19, 2020, the Company received its formal Notice of Issuance from the U.S. Patent and Trademark Office (USPTO) for its patent application 15/426,617.

The patent covers methods of treating smokeless tobacco addiction by administering pharmaceutical formulations containing CBD and nicotine. The communications between the USPTO and the Company conclude substantive examination of the patent application, resulting in formal issuance of the patent. CV Sciences has also filed corresponding patent applications that will allow the Company to seek similar patent protection in other key markets throughout the world.

The worldwide smokeless tobacco addiction treatment market is estimated at greater than $2 billion and provides another important long-term growth channel for CV Sciences, in addition to the Companys consumer product segment.

USPTOs patent issuance demonstrates that our proprietary technology, the first-of-its-kind treatment for smokeless tobacco addiction, is based on unique science backed by years of research and development, said Joseph Dowling, Chief Executive Officer, CV Sciences. This intellectual property positions CV Sciences to derive significant value from our development efforts with an important therapeutic drug that has the potential to transform healthcare given the public health, societal and economic damage caused by nicotine addiction. With this patent, our years of investment, research and hard work is now validated, and we are well positioned and proud to take the next steps towards bringing to market an innovative solution to address a huge unmet medical need and global health issue.

Dowling continued, The validation of patent protection provides CV Sciences with significant flexibility in moving this drug program forward, including potential co-development with a strategic and/or financial partner, as well as drawing on existing company resources to finance our drug development activities.

In light of this patent issuance, the Company has decided to form a new wholly-owned C-Corporation to which it will transfer the assets and operations of its drug development program, providing the Company with greater flexibility to fund and/or partner its drug development efforts and to separate a distinct operating segment from its consumer products operations.

The Companys initial drug candidate (CVSI-007) contains nicotine and CBD to support cessation of smokeless tobacco use and addiction. With USPTOs formal issuance of the patent, CV Sciences will continue development efforts as the Company seeks approval from the U.S. Food and Drug Administration (FDA) to commercialize the worlds first and only FDA-approved treatment for smokeless tobacco addiction.

About CV Sciences, Inc.

CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics. The Companys PlusCBD Oil products are sold at more than 5,700 retail locations throughout the U.S. and it is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences state-of-the-art facility follows all guidelines for Good Manufacturing Practices (GMP) and the Companys full spectrum hemp extracts are processed, produced, and tested throughout the manufacturing process to confirm the cannabinoid content meets strict company standards. With a commitment to science, PlusCBD Oils benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. PlusCBD Oil was the first hemp CBD supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. CV Sciences, Inc. has primary offices and facilities in San Diego, California. Additional information is available from OTCMarkets.com or by visiting http://www.cvsciences.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

CONTACT INFORMATION:Investor Contact:ICRScott Van Winkle617-956-6736scott.vanwinkle@icrinc.com

Media Contact:ICRCory Ziskind646-277-1232cory.ziskind@icrinc.com

Read the original post:

CV Sciences, Inc. Receives Formal Notice of Patent Issuance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating...

Denver, Colorado, May 19, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Global Sciences Inc. (CSE: CBDN;OTC: CBDNF;Frankfurt: GS3),(CBD Global or the Company), is pleased to announce the start of the 2020 hemp planting season, at our wholly-owned Colorado subsidiary Strasburg Pharms, has begun. This is the Companys 6th straight year of Hemp production at our 179-acre site. The Company has brought in additional farming expertise this season and, along with our first year of implementing expanded use of feminized seed, we will also be employing some additional techniques that we believe will greatly expand our yields while at the same time significantly reduce our costs per pound of produced biomass.

The 2020 growing season has arrived at Strasburg Pharms, Colorado, and we look forward to building on the progress we made with the previous years harvests, commented Brad Wyatt, President and CEO. We look forward to working with our team to optimize all aspects of cultivation and to deliver on a larger mission of bringing wellness to people so they can live happier and healthier lives.

In order to meet the growing demand for quality CBD products throughout the US, the Company will be planting in excess of 1.7 million feminized seeds which have been derived from our previous high yielding CBD strains. Hemp with higher potency CBD content reduces the amount of biomass required for CBD extracts allowing the maximum benefit in the production of cannabinoids, terpenes and other beneficial compounds. The biomass will be used to create our CBD products sold under our own brands, Aethics and CannaOil, and also for fulfilling orders for our select white label partners throughout the US and other parts of the world.

Our hemp is 100% Colorado grown with all-natural Colorado water, soil, sun and nutrients and NEVER sprayed with pesticides or chemicals. The hot summer days and cool Colorado nights creates the perfect environment for hemp cultivation. On top of that, at 5280 feet above sea level, the farm enables more potent UV rays presenting the perfect state for the plants natural photosynthesis reactions to facilitate maximum plant potency and growth.

In addition to the foregoing, CBD Global also announces the grant of an aggregate of 6,000,000 options to acquire common shares of the Company to officers, directors, employees and consultants of the Company, each such options being exercisable at a price of CDN$0.20 per common share for a three-year term expiring on May 19, 2023. These stock options all vest over a 2-year period with one-third vested immediately upon the date of grant and further one-third vesting on each of the first and second anniversaries of the date of grant.

ABOUT CBD GLOBAL SCIENCES INC.

CBD Global Sciences Inc., is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals and CBD hydration products. CBD Globals hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.

CBD Global Sciences, through its wholly owned subsidiary, Strasburg Pharms, grows and operates irrigated land in Colorado that grows hemp with only all-natural Colorado water, soil, sun and nutrients that is NEVER sprayed with pesticides or chemicals. Our genetics are hand selected and maintained to present the best cannabinoid profile with extremely high CBD. The extraction/processing facility, operated by CBD Global, is located approximately 40 minutes from the farm.

For further information, please contact Bruce Nurse, Investor Relations, (303) 919-2913,info@cbdglobalsciences.com.

https://www.cbdglobalsciences.com

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation after the CSE listing. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and otherfactors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Story continues

Read more here:

CBD Global Sciences Commences Its 6th Year of Planting at Its Strasburg Pharms Subsidiary - Yahoo Finance